Skip to main navigation
Skip to search
Skip to main content
Sort by
Keyphrases
Multiple Sclerosis
100%
Microglia
54%
Multiple Sclerosis Treatment
23%
Dysferlin
22%
CD200
22%
Disease Progression
22%
Lesion Formation
21%
Cerebrospinal Fluid
21%
Progressive multiple Sclerosis
21%
Multiple Sclerosis Lesions
21%
Cluster of Differentiation 47 (CD47)
20%
Central Nervous System
19%
Histological Markers
18%
Imaging Biomarkers
18%
Signal Control
18%
Neuronal Loss
18%
Zinc Finger Protein
18%
Relapsing-remitting multiple Sclerosis
18%
Inflammation
14%
Demyelination
14%
Microglial Nodules
12%
Myeloid Cells
12%
Gray Matter Volume
12%
Lesion Types
12%
Multiple Sclerosis Severity Score
12%
Brain Bank
12%
Netherlands
12%
Multiple Sclerosis Severity
9%
CNS Pathologies
9%
Gray Matter
9%
Glial Fibrillary Acidic Protein
9%
Neuropathology
9%
System Resilience
9%
Oxylipins
9%
Microglia/macrophages
9%
Ramified Microglia
8%
Postmortem Tissue
8%
Accruals
8%
Tissue Damage
8%
Normal-appearing White Matter
7%
Neurodegeneration
7%
Brain Homeostasis
7%
Autopsy
7%
Multiple Sclerosis Progression
7%
B-cell Maturation Antigen
7%
Alzheimer's Disease
7%
Soluble CD27
7%
Disability
7%
Positron Emission Tomography Study
6%
Rapid Progression
6%
Neuroscience
Multiple Sclerosis
85%
Microglia
46%
Dysferlin
20%
G Protein Coupled Receptor
18%
Zinc Finger
18%
Glial Fibrillary Acidic Protein
17%
Gray Matter
13%
Osteopontin
12%
Neurofilament Light Chain
12%
Alzheimer's Disease
12%
B Cell Maturation Antigen
12%
CD27
12%
Central Nervous System
11%
Neuromodulation
9%
Neuronal Activity
9%
Biological Marker
9%
Chitinase
8%
Synaptosomal Associated Protein 25
8%
Neuromyelitis Optica
8%
Neurodegeneration
6%
Genetics
5%
Immunology and Microbiology
Multiple Sclerosis
85%
Microglia
30%
CD200
19%
Gray Matter
18%
Central Nervous System
13%
Cerebrospinal Fluid
11%
White Matter
7%
Macrophage
7%
Myeloid
6%
Brain Tissue
5%
Transcriptomics
5%